- About
- Advertise
- CureToday.com
- OncLive.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
American Society for Transplantation and Cellular Therapy
The American Society for Transplantation and Cellular Therapy (ASTCT) is an international professional membership association of more than 2,600 physicians, investigators and other healthcare professionals from more than 45 countries. Our mission is dedicated to improving the application and success of blood and marrow transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field. Learn more at astct.org.
Latest from American Society for Transplantation and Cellular Therapy
KIR-ligand Mismatch in CBT Outcomes Differ Based on GVHD Prophylaxes
November 22, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing the use of killer immunoglobulin-like receptor–ligand mismatch and its impact on graft versus host disease.
Factors Affecting Tacrolimus Concentrations in Children with β-Thalassemia Major receiving HSCT
November 15, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing the impact of genotype and voriconazole co-administration on tacrolimus trough concentration in pediatric β-thalassemia major patients following allogeneic hematopoietic stem cell transplantation.
Learn the Latest In CAR T with ASTCT Webinars
November 08, 2021
Article
Join ASTCT for a series of webinars that focus on topics relating to CAR T.
Interim Findings from the EQUATE Study Demonstrate Safety and Efficacy of Itolizumab
November 08, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing the EQUATE study and its use of itolizumab.
UK Researchers Develop Simplified Manufacturing Process for CAR T Cells
November 01, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing a simplified manufacturing process for CAR T cells.
Chinese Researchers Identify Risk Factors for Poor Treatment Response to CAR T Therapy in ALL Patients
October 25, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing CAR T therapy in patients with acute lymphoblastic leukemia.
Anti-SARS-CoV-2 mRNA Vaccination After CAR T Therapy “Is Safe but Seroconversion Rate Is Low”
October 18, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing the COVID-19 vaccine after CAR T therapy.
Rapamycin Pre-Treatment of CAR T Cells “May Enhance Therapeutic Efficacy Against AML”
October 04, 2021
Article
A recently published article on CAR T cells in patients with acute myeloid leukemia is featured by CancerNetwork's Strategic Alliance Partner ASTCT.
Infusion of HER2-Specific CAR T Cells into Brain or CNS “Feasible” in Pediatric Patients
September 27, 2021
Article
ASTCT recently published an article in their journal Nucleus detailing CAR T-cell in pediatric patients with brain cancer.
A Deep Dive On Early Time-to-Tocilizumab
September 20, 2021
Article
The latest episode of the ASTCT Talks features Rahul Banerjee, MD, on bone marrow transplant and CAR-T therapy.
Outpatient Haploidentical Stem Cell Transplantation
September 14, 2021
Article
The latest episode of the ASTCT Talks episode features a discussion from Andrés Gómez De León, MD, and Perla Colunga, MD, on outpatient haploidentical stem cell transplantation.
Advancements in Immunotherapies With John DiPersio, MD, PhD
September 13, 2021
Article
The latest episode of the ASTCT Talks episode features John DiPersio, MD, PhD, on emerging therapies in the treatment of acute myeloid leukemia.